Heidi M. Brun (Audit Committee)
Winner of Client Choice 2017 Award, MIT
An MIT graduate with multiple degrees in Mechanical Engineering, Heidi has been a patent attorney in Israel and a US patent agent for 30 years. Heidi has written patents in all the high-tech fields. She specializes in turning complicated concepts and highly mathematical ideas into readily understandable patent applications.
In 2002, Heidi opened Heidi Brun Associates as a boutique patent firm, specializing in generating high quality patents. In 2011, she merged Heidi Brun Associates with Eitan, Mehulal and Sadot, becoming head of their Strategic Patent Department. In 2017, she returned to Heidi Brun Associates once again, to build a boutique patent firm.
Dr. Shimon Eckhouse
Dr. Shimon Eckhouse is a Co-Founder of Syneron Ltd (NASDAQ: ELOS) and serves as its Active Chairman. Syneron is active in the area of non-invasive technology for aesthetic/medical procedures. Syneron has grown since its inception in September 2000 to sales of $117M in 2006. The company became public on NASDAQ in August 2004 and completed a $225M secondary offering in March 2005.
Dr. Eckhouse is also the founder of a few start-up companies in Israel including Cardiodex specializing in cardiology, NanoCyte specializing in the area of trans-dermal drug delivery, Colorchip specializing in integrated optics for telecom applications, Orsense developing non-invasive glucose measurement devices, Ventor in the area of cardiology, Navotek specializing in medical tracking technology and Tulip specializing in obesity treatments as well as a few other companies.
Dr. Eckhouse was the founder, Chairman and CEO of ESC Medical from its inception until 1999, bringing the company from a concept that he invented in 1992 to revenues of more than $220M in 1998. During this period he developed the distribution channels of the company, created a worldwide sales and marketing organization with direct sales forces in the US, major EEC countries and Japan and a network of more than 50 distributors in other countries. Dr. Eckhouse took ESC Medical public in 1996 and raised more than $250M in 3 public offerings in 1996 and 1997.
Prior to starting ESC Medical, Dr. Eckhouse was Head of Product Development and Technical Director at Maxwell Technologies in San Diego, CA. From 1986 to 1990, Dr. Eckhouse was a scientist, team leader and head of a department in Rafael, Armament Development Authority of Israel and was active in areas of research and development including lasers and electro-optics. Dr. Eckhouse holds a BSc degree in Physics from the Technion Israeli Institute of Technology and a PhD degree in Physics from UC Irvine. He has more than 25 registered patents and published more than 50 papers in leading refereed journals and conferences. He is also a member of the Board of Directors of the Technion Israeli Institute of Technology.
Prof. Ronit Satchi Fainaro
Ph.D. University of London
Chair, Department of Physiology and Pharmacology, Sackler Faculty of Medicine at Tel Aviv University
Current - Full Professor at Tel Aviv University, Chair, Department of Physiology and Pharmacology, Sackler Faculty of Medicine at Tel Aviv University
Past - Associate Professor at Tel Aviv University, Visiting Associate Professor at Harvard Medical School, Assistant Professor at Tel Aviv...
Education - Harvard Medical School, Tel Aviv University, University of London, The Hebrew University
Prof. Meir Feder
Co-Founder & Chief Scientist Amimon
Meir Feder, Co-Founder & Chief Scientist, Amimon
Meir Feder is a Professor at the Department of Electrical Engineering - Systems, Tel-Aviv University. He is an internationally recognized authority in signal processing and information theory and has published well over 100 journal and conference papers, mostly on data compression and communications. During his academic career, Professor Feder consulted with numerous high-tech companies, including Intel on designing efficient multimedia algorithms for the MMX architecture. In 1998 he co-founded Peach Networks, a provider of server-based interactive TV systems, which was later acquired by Microsoft and in 2000 he co-founded Bandwiz, a producer of content delivery systems for enterprise networks. Prof. Feder began his professional career as an R&D engineer and manager in an elite R&D unit of the Israeli Defense Forces, where he received the "Creative Mind" award for his technical achievements. An IEEE Fellow with several academic awards to his credit, Prof. Feder holds an Sc.D. degree from the Massachusetts Institute of Technology.
Prof. Feder is an MIT Alumni.
Manager, Technical Marketing MathWorks
Silvina Grad-Freilich is the Product Manager for distributed computing and application deployment products at The MathWorks. Silvina holds both B.Sc and M.Sc. degrees in Computer Science from the National University of La Plata in Argentina and a M.Sc. in Management from the Massachusetts Institute of Technology.
Silvina is an MIT Alumnus.
Executive Chairman & Co-Founder at UpStay
Ishay Green is a software architecture professional, with over 17 years of experience. Ishay Co-Founded Soluto in 2008, the company that initiated the PC Genome™ project. Prior to co-founding Soluto, Ishay founded Onigma LTD which was acquired by McAfee after 22 months from initiation. Before that, Ishay worked as a senior software engineer in Envara (acquired by Intel). Ishay also served as a Software Architect and a consultant in several high-tech companies; amongst them are ContactNow, Orckit Communications and Passave. Mr. Green served in the elite Electronic Research and Development Department of the Israeli Ministry of Defense.
Mr. Green holds a BA in Computer sciences from the Interdisciplinary Center of Hertzeliya (IDC).
Co-founder and Board Member at EarlySense, MIT Sloan School
Mr. Halperin is a veteran high tech executive. He has served in several senior management positions including CEO of Emmunet, VP Marketing at Radcom (NASDAQ: RDCM), and VP of Business Development at Lenslet.
He also worked as the R&D Manager at Eldat and was the Department Head of an R&D Unit in the IDF Intelligence Corps, where he participated in the Talpiot Project.
Mr. Halperin earned a M.Sc. in Applied Physics from Tel Aviv University and an MBA from the MIT Sloan Fellows Executive MBA Program.
CEO, O2Cure Ltd.
Hezi joined O2Cure in May 2019, bringing with him more than 30 years of management and development experience in hi-tech and medical device companies. Hezi’s last role was General Manager and Chief Operating Officer in Microbot Medical (Nasdaq: MBOT) that develops micro-robotic devices in the neurology area. Prior to Microbot, hezi was the CEO of IceCure Medical, a TASE publicly traded company that develops advanced cryotherapy systems (cryoablation) intended for the growing physician-office market in the women’s Health and other areas. During his 8.5 years in IceCure, Hezi was responsible for establishing a U.S subsidiary (Memphis, TN) for sales, marketing, clinical and technical support, increasing reimbursement coverage in the U.S and leading the company's transition from clinical phase to commercial sales. Before Joining IceCure, Hezi was the CEO of Remon Medical Technologies, leading the company from an early stage incubator start-up, through several innovation and development cycles, including successful human trials in the U.S, Europe and Asia. At the end of 2008, Hezi led the acquisition of Remon by Boston Scientific ($100M+). Prior to Remon, Hezi spent 4 years in Medtronic InStent Israel. At Medtronic, he was responsible for, the integration of InStent into Medtronic’s vascular group and managing the company’s Israeli facility, including managing clinical studies in the U.S, Europe and Asia as well as marketing activities. Prior to Medtronic, Hezi spent 14 years at Scitex Corporation, where he held positions including engineering manager, hardware designer, software programmer and project leader. Hezi holds a B.Sc. in electronic engineering and an M.B.A , both from Tel-Aviv University.
An entrepreneur and senior executive with a great passion to technology and innovation, Elan has more then 25 years experience in leading start-ups to success.
In 2011 Elan co-founded Appforma and served as its CEO. Appforma developed a unique SaaS, AI based social media marketing platform that enables e-tailers to automatically create and manage their online social marketing campaigns. In 2016 Appforma's was acquired by Algomizer (TASE: ALMO).
Between 2008-2010 Elan was the CEO of Interlogic. The company was the developer & operator one of the world’s largest online gaming platforms in its domain, Play65. In its peak the company had an annual turnover of over $40M.
In 2004 Elan co-founded Leanway and served as its CEO. Leanway pioneered the field of Complex Event Processing (CEP) technology in a Big Data environment. The company enabled large enterprises to easily modify their systems to process up-to 50x more data and transactions/sec with very high ROI. In 2007, Leanway was acquired by Amdocs (NYSX:DOX).
Between 2000 and 2014 Elan served as the CEO of iMash. During this time iMash became one of the world's leading file-sharing (P2P) companies (with Napster and later Kazza) and a highly profitable one. In 2003 iMash was chosen as one of the leading Internet companies in Israel.
Co-founder and head of business development BSP Funds
Ran Perlman has been an entrepreneur in the high tech, industry and financial sectors. With more than 25 years of experience.
Ran co founded Flash Networks a high tech company which developed enhancement tools for the wireless data transfer communication technologies.
Co-founded Marionette-Tech a company that developed remote activation technology for the toy industry and sold the rights to Tiger Electronics.
Seed investor and board member in Rad-Vision (RVSN)
Seed investor in Whale-Com (sold to Microsoft)
Co-founder in Rin-Electronicash Systems.A smart card RSA solution company for electronic small payments.
Co-founder of A.Perlman Investments LTD, a privately owned company that has been investing seed money in start ups and also in local industry focused on exportation.
Currently co-founder and head of business development in BSP Funds LTD, a Canadian-Israeli company specializing in research and investments in the hedge funds industry, using unique sophisticated proprietary tools and software to enhance the due diligence process.
Mr. Perlman holds a BA in Economics from Tel Aviv university.
Founder and Former General Director of The Israeli Program of Technological Incubators
An attorney, graduate of the Hebrew University's Law school and a member of the Israeli Bar.
Participated in the early seventies in establishing the office of the Chief Scientist in the Ministry of Industry & Trade.
In 1978 moved to the private sector joining Worldtech Israel Ltd,
a private company representing foreign investments in industrial R&D projects in Israel.
Appointed in 1984 as CEO of the company.
Through Worldtech Ltd. More than 30 $ million were raised in the U.S. and invested in Hi-tech companies in Israel, Start ups' seed money mainly.
Among those start ups were: Teledata, Efrat (Comverse), Oshap/Robcad
(Technomatics) and Lannet - Today leading Hightech public companies.
In 1991 joined again the office of chief scientist in order to establish and operate the Technological Incubators program in Israel.
In her current capacity as the Director of the program, she is in charge of creating the program's framework and its implementation, setting objectives and rules, managing and operating of Government support budget.
Within the frame of this program 24 Technological incubators are operational. Hundreds of R&D projects have been carried out by novice inventors and entrepreneurs which led to new Hi- tech Start -ups.
The program's annual Governmental budget is 35 million dollars.
Daniel S. Recanati
Founder and CEO of Rhodium
Daniel S. Recanati is the Founder and CEO of Rhodium, a private investment firm whose mission is to identify the most promising entrepreneurs and help them build thriving companies.
Rhodium focuses on high growth and cutting-edge opportunities in the fields of Internet, new-media, mobile, and new technologies in general. Rhodium supports entrepreneurs and strengthens their ventures with its resources: funding, broad management expertise, and a valuable and extensive network of business contacts around the globe.
Rhodium vision is to partner with talented entrepreneurs to turn their ideas into industry-leading companies that will make an impact on our world. Looking to take an active role in its portfolio companies, Rhodium strategically invests in a number of promising startups each year and creates the optimal environment for them to successfully transform into world-class business ventures.
Rhodium's specialties include Internet, new media, and mobile. More information can be found at www.rhodium.co.il.
Daniel S. Recanati is involved in many community organizations such as The Israel National Museum of Science Technology and Space (MadaTech), The Yahel Foundation and Apple Seeds Academy (Tapuah) - The Israeli Society for the Advancement of the Information Age.
Rami Reiss (Audit Committee)
VP R&D at FruitSpec .
Senior R&D manager with extensive experience in building and leading large R&D product and project organizations. Leader and team player, performing in multi-disciplinary business environments combining marketing, sales, engineering and R&D.
Rami is in charge of MIT EF Israel's consluting activity.
Yuval is a lecturer on Finance & Engineering Economy and Information Systems Analysis at the Tel Aviv University, Faculty of Engineering. Yuval is also a co-lecturer in Business Entrepreneurship courses at Tel Aviv University and had been a teaching assistant in Entrepreneurship and Engineering courses at Tel Aviv University, the Herzliya Interdisciplinary & the MBA program of the Technion. Yuval won the distinguished Rector's award for his achievements in teaching.
For the past 5 years, Yuval has served as the manager of the MIT Forum’s consulting program. In addition to consulting for the MIT Forum, Yuval also consults to start-up companies in the fields of Internet, Apps and software.
Yuval is highly involved with the GEW, Global Entrepreneurship Week, in Israel. Global Entrepreneurship Week connects people through local, national and global activities designed to help them explore their potential as self-starters and innovators.
Yuval is also a project manager and TOC consultant for project management at Malam. TOC Solution design adjusted to the organization's work processes. Managing the implementation of Execution Management System and implementing TOC methodology in project management
Yuval is a cum laude alumnus of the Tel Aviv University School of Engineering (M.Sc). Yuval completed his military service in 2002, where he served in the intelligence unit.
Co-Founder and CEO, OneHourTranslation
Ofer is Co-Founder and CEO of One Hour Translation, one of the world's leading professional translation services.
One Hour Translation has over 30,000 professional translators and it provides High quality, Fast, 24/7 translation.
Ofer has over 18 years of experience in starting and managing high-tech companies around the world. Ofer was Founder and CEO of Qlusters, under his leadership Qlusters became the #1 open source system management solution, prior to that he was founder and CEO of Coretech, a company that developed a life-saving cardiological device, VP Business Development at RichFX, an Internet technology company, and VP Marketing and Business Development of Comsec Information Security.
Ofer had also been retained as a strategic consultant by many major corporations including CheckPoint (CHKP) and others. Ofer is member of the board of the MIT Enterprise forum. Ofer has an MBA from INSEAD.
Co-founder & President, Mellanox
Eyal Waldman is a co-founder of Mellanox, and has served as Mellanox's president and chief executive officer since March 1999. From March 1993 to February 1999, Mr. Waldman served as vice president of engineering and was a cofounder of Galileo Technology Ltd., or Galileo, a semiconductor company, which was acquired by Marvell Technology Group Ltd. in January 2001. From August 1989 to March 1993, Mr. Waldman held a number of design and architecture related positions at Intel Corporation, a manufacturer of computer, networking and communications products. Mr. Waldman holds a Bachelor of Science in Electrical Engineering and a Master of Science in Electrical Engineering from the Technion Israel Institute of Technology.
Dr. Ronald Weissman
Chairman of the Software Group of the Band of Angels, Silicon Valley’s oldest angel organization.
Dr. Weissman has been a Band member since 2007. He is also a member of the Board of Directors of the Angel Capital Association. He has more than twenty years of experience in venture and angel capital.
Ron was a Partner and portfolio manager for seventeen years at Apax Partners, a global venture capital firm, where he focused on cross-border investing and enterprise software.
Ron regularly advises financial and corporate venture funds, national and regional governments and G2000 innovation programs about startup ecosystems and venture/angel capital. He also regularly advises companies and funds about business relationships, AI investing best practices and trends, term sheets, valuation and other aspects of corporate deal-making and on SaaS-related business models.
Prior to Apax, he was Chief Marketing Officer and head of Investor Relations at Verity (the market leader in enterprise knowledge retrieval). Verity’s management team won Large Cap Turnaround of the Year (Turnaround Management Association) after the company increased its market cap, profitably, from $50M to nearly $2B. Ron also ran Verity’s successful secondary offering in 1999. Prior to Verity, he directed Strategic Marketing and European Marketing for NeXT, reporting directly to Steve Jobs. Before joining NeXT in 1990, Ron was a consultant to many federal agencies on issues relating to IT strategy and on the faculties of Brown University and the University of Maryland.
Ron invests in enterprise software, IoT, Fintech, analytics and AI solutions and in Health IT. Between his twelve years as an active angel and his VC career, Ron has led or co-lead 35+ investments, has advised 75+ companies and has served on 30+ Boards of Directors and has had many successful IPO and M&A outcomes. He has judged many pitch events in the US and abroad, has heard thousands of pitches and has mentored or coached many startup teams. He also regularly offers free public training in raising entrepreneurial capital, valuation and term sheet best practices.
Founder and CTO at Gbooking LTD
Dr. Nuha Hijazi
Ph.D in piron disease, Chief Technology Officer 0f Plas-free
Dr. Nuha Higazi has a Ph.D in Neurology from the Hebrew University, Hadassah Medical
Center, Jerusalem. Dr. Higazi has a career of 8 years in the Bio-tech field. She has
a strong and diverse scientific background. Dr. Higazi was the CTO of Pam-Bio, a
biotech company developing drug therapy for Hemorrhagic stroke (intracranial
bleeding, ICH) and other acute bleeding conditions. Prior to joining Pam-Bio, Dr.
HIgazi served as a Post-Doc in the Hematology department in the Hadassah medical
school, Jerusalem. Dr. Higazi is the author of 8 scientific publications and inventor of
2 patent applications.
Dr. Mahmood Kanana
Founder & CEO at MagicalSnoreless